Showing results (141-150 of 216) with videos related to
Sort By:
Pageof 22
Therapeutics and Clinical Risk Management|July 2, 2020
Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 TrialRunhui Wu, Jing Sun, Weiqun Xu, et al.Stem Cells and Development|April 13, 2017
The State of Skewed X Chromosome Inactivation is Retained in the Induced Pluripotent Stem Cells from a Female with Hemophilia BCuicui Lyu, Jun Shen, Jianping Zhang, et al.Biochemical and Biophysical Research Communications|July 4, 2006
Proliferation and differentiation of bone marrow stromal cells under hypoxic conditionsHongying Ren, Ying Cao, Qinjun Zhao, et al.Current Medical Research and Opinion|May 24, 2017
Status and trend analysis of prophylactic usage of recombinant factor VIII in Chinese pediatric patients with hemophilia A: ReCare - a retrospective, phase IV, non-interventional studyChanggang Li, Xinsheng Zhang, Yongqiang Zhao, et al.Hematology (Amsterdam, Netherlands)|October 6, 2025
The effectiveness and safety of various treatments for hemophilia in China: a literature review and evidence mappingYu Yang, Jing Zhang, Lingling Chen, et al.Haematologica|April 14, 2011
Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I GroupTienan Zhu, Qiulan Ding, Xia Bai, et al.Haematologica|June 12, 2025
Artificial intelligence-based quantitative bone marrow pathology analysis for myeloproliferative neoplasmsDandan Yu, Hongju Zhang, Yanyan Song, et al.Blood Advances|February 4, 2026
A specific FX activator for bleeding treatment in hemophilia with inhibitors: multicenter, open-label, phase I/II trialsWei Liu, Hu Zhou, Ruibin Huang, et al.The New England Journal of Medicine|April 8, 2026
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune ThrombocytopeniaDavid J Kuter, Katsuhiro Miura, Andrea Patriarca, et al.Journal of Thrombosis and Thrombolysis|May 30, 2023
Machine learning analyses constructed a novel model to predict recurrent thrombosis in adults with essential thrombocythemiaJia Chen, Huan Dong, Rongfeng Fu, et al.Pageof 22